Bessemer Group Inc Vericel Corp Transaction History
Bessemer Group Inc
- $61.6 Billion
- Q2 2025
A detailed history of Bessemer Group Inc transactions in Vericel Corp stock. As of the latest transaction made, Bessemer Group Inc holds 17,362 shares of VCEL stock, worth $601,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,362
Previous 10,175
70.63%
Holding current value
$601,419
Previous $455,000
62.42%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$123 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.4 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$85.3 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.63B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...